Literature DB >> 22423624

Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma.

Olga Pozdnyakova1, Elizabeth A Morgan, Betty Li, Ali Shahsafaei, David M Dorfman.   

Abstract

Plasma cell neoplasms are common hematopoietic malignancies that recently have been shown to be driven by specific genetic events. In the past decade, immunophenotyping by flow cytometry has become an important tool in the characterization of plasma cells. However, the clinical and prognostic significance of antigenic expression remains unclear. We analyzed 102 cases of plasma cell neoplasm by flow cytometric immunophenotyping for expression of CD56 and CD117 and correlated the results with immunohistochemical and cytogenetic findings. Expression of CD56 and CD117 was associated with hyperdiploidy and the absence of CD117 expression was associated with different immunoglobulin heavy chain gene (IGH) translocations. Assessment of CD117 expression on neoplastic plasma cells by flow cytometry is superior to immunohistochemistry. Simultaneous assessment of CD56 and CD117 expression by flow cytometry is a sensitive method for diagnostic evaluation of plasma cell neoplasms, and furthermore may function as a rapid adjunctive test providing independent prognostic information in the absence of cytogenetic data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22423624     DOI: 10.3109/10428194.2012.676174

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

1.  Antigen Expression Patterns of Plasma Cell Myeloma: An Association of Cytogenetic Abnormality and International Staging System (ISS) for Myeloma.

Authors:  Sang-Yong Shin; Seung-Tae Lee; Hee-Jin Kim; Suk Jin Kim; Kihyun Kim; Eun Suk Kang; Sun-Hee Kim
Journal:  J Clin Lab Anal       Date:  2014-10-02       Impact factor: 2.352

2.  Small-lymphoid cells and myeloid antigen expression in a patient with IgG myeloma: A case report.

Authors:  Pengjun Jiang; Wen Xia; Xuemei Sun; Xingbin Dai; Lin Li
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

3.  Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies.

Authors:  Simona Caltagirone; Marina Ruggeri; Simona Aschero; Milena Gilestro; Daniela Oddolo; Francesca Gay; Sara Bringhen; Caterina Musolino; Luca Baldini; Pellegrino Musto; Maria T Petrucci; Gianluca Gaidano; Roberto Passera; Benedetto Bruno; Antonio Palumbo; Mario Boccadoro; Paola Omedè
Journal:  Haematologica       Date:  2014-07-11       Impact factor: 9.941

4.  Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities.

Authors:  Mohamed E Salama; Shouying Du; Olga Efimova; Nahla M Heikal; Erik Wendlandt; Reha M Toydemir; Sarah South; Sherrie L Perkins; Jerry W Hussong; Fenghuang Zhan
Journal:  Leuk Lymphoma       Date:  2014-08-04

5.  The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients.

Authors:  Funda Ceran; Mesude Falay; Simten Dağdaş; Gülsüm Özet
Journal:  Turk J Haematol       Date:  2017-03-08       Impact factor: 1.831

6.  Osteolytic Lesion of the Maxilla in an Undiagnosed Multiple Myeloma Patient Identified Incidentally by Cone Beam Computed Tomography.

Authors:  Sarah AlFarabi Ali; Hanadi M Khalifa; Amr Bayoumi; Soulafa AlMazrooa; Nada O Bin Madi; Sara Akeel; Amal M Sindi
Journal:  Am J Case Rep       Date:  2022-08-16

7.  Prognostic significance of CD56 antigen in newly diagnosed multiple myeloma: A real-world retrospective study.

Authors:  Liping Li; Xiaofeng Li; An Shang; Yan Zhao; Lifang Jin; Meng Zhao; Weizhang Shen
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

8.  Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.

Authors:  Iole Cordone; Francesco Marchesi; Serena Masi; Valentina Summa; Francesco Pisani; Roberta Merola; Giovanni Cigliana; Giulia Orlandi; Svitlana Gumenyuk; Francesca Palombi; Atelda Romano; Antonio Spadea; Daniela Renzi; Elena Papa; Marco Canfora; Laura Conti; Maria Concetta Petti; Andrea Mengarelli
Journal:  J Exp Clin Cancer Res       Date:  2016-03-19

9.  Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis.

Authors:  Fang Chen; Yanping Hu; Xiaohui Wang; Shuang Fu; Zhuogang Liu; Jihong Zhang
Journal:  Cancer Med       Date:  2018-10-24       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.